Statins and sepsis: do we really need to further decrease monocyte HLA-DR expression to treat septic patients?

Lancet Infect Dis. 2007 Nov;7(11):697-9. doi: 10.1016/S1473-3099(07)70245-1.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • HLA-DR Antigens / immunology
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use*
  • Monocytes / immunology
  • Sepsis / drug therapy*
  • Sepsis / immunology

Substances

  • HLA-DR Antigens
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors